Irbesartan Tablet
Product Images NDC 71205-082

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71205-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure diagram of Irbesartan, illustrating its molecular configuration with labeled rings and bonds consistent with the generic drug Irbesartan.*

FDA Label Image

Figure 1 (Spl Image2 Figure1)

A graph depicting the placebo-subtracted reduction in trough SeSBP as a function of Irbesartan dose (mg/day). The y-axis shows pressure in mmHg, and the x-axis shows Irbesartan dose up to 900 mg/day. Data points and a fitted curve illustrate the dose-response relationship, with greater blood pressure reduction at lower doses leveling off at higher doses.*

FDA Label Image

Figure 2 (Spl Image3 Figure2)

A scatter plot chart illustrating the placebo-subtracted reduction in trough SeDBP as a function of Irbesartan dose in mg/day, with a curve fit to the data representing an integrated analysis. The x-axis displays Irbesartan dose from 0 to 900 mg/day, and the y-axis shows blood pressure reduction in mmHg from -2 to 8 mmHg.*

FDA Label Image

Figure 3 (Spl Image4 Figure3)

A Kaplan-Meier cumulative event rate graph comparing Irbesartan, Amlodipine, and Placebo over months of follow-up up to 60 months. The graph shows cumulative event percentages on the y-axis and months on the x-axis, with statistical annotations for relative risk (RR) and p-values comparing Irbesartan to Placebo and Amlodipine.*

FDA Label Image

71205-082-30 (Spl Image6 Irbesartan 150mg)

Irbesartan 150 mg tablets packaging label from Proficient Rx LP. The label indicates 30 tablets per container with each tablet containing 150 mg of Irbesartan. It includes lot number, expiration date placeholders, storage instructions at 20°-25°C, and the manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd. Information about the tablet appearance and debossing ('HH' and '330') is also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.